123 results
Page 3 of 7
8-K
EX-99.1
p0ttp03pj5tr5 v2gk
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
S-8
EX-5.1
6mx5i3u4abukz
17 Mar 21
Registration of securities for employees
4:06pm
S-8
0ks7be je9
17 Mar 21
Registration of securities for employees
4:06pm
8-K
EX-10.1
k0h2t
16 Feb 21
Entry into a Material Definitive Agreement
7:10am
424B5
q81 aioxq6bdo6
16 Feb 21
Prospectus supplement for primary offering
7:05am
8-K
EX-10.1
5w9o9nr3ikggrd
4 Jan 21
Aravive Announces Board Member Transition to Advisory Role
4:11pm
8-K
EX-10.1
b2ltznphka n8p
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
8-K
EX-10.1
w6d1 7rpj3npp
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
8-K
EX-10.3
vo8z74 bfvrz
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
S-8
EX-5.1
rwq0nmiv1oq9q2fz836
27 Mar 20
Registration of securities for employees
8:38am
S-8
6t3b hey7int
27 Mar 20
Registration of securities for employees
8:38am